Biodelivery Sciences International Profit Margin

Biodelivery Sciences International (BDSI) currently reports a profit margin of 50.9% as of December 2021. That compares with 16.43% in the prior-year period — up 209.8% year over year. That is above the Healthcare sector average of 15.58%. Use the charts on this page to explore Biodelivery Sciences International's profit margin history and peer comparisons.

Biodelivery Sciences International's profit margin increased from 16.43% to 50.9% — a 209.8% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biodelivery Sciences International's profit margin of 50.9% is higher than the Healthcare sector average of 15.58%. That is roughly 226.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biodelivery Sciences International's current 50.9% should be judged against Healthcare norms (sector average: 15.58%) and against BDSI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 50.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Biodelivery Sciences International, and consider following BDSI for alerts when major investors trade the stock.